Cart
sales@molnova.com
TRX818
CAS No. 1256037-58-7
TRX818( —— )
Catalog No. M17224 CAS No. 1256037-58-7
TRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 50 | In Stock |
|
| 5MG | 88 | In Stock |
|
| 10MG | 143 | In Stock |
|
| 25MG | 216 | In Stock |
|
| 50MG | 333 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTRX818
-
NoteResearch use only, not for human use.
-
Brief DescriptionTRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
-
DescriptionTRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Met/HGFR
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1256037-58-7
-
Formula Weight393.21
-
Molecular FormulaC16H11FNNa2O5P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESc12c(c(c(cc1)OC)P(=O)([O-])[O-])c(=O)cc([nH]2)c1cc(ccc1)F.[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
TAE226
NVP-TAE226 is a potent FAK inhibitor with IC50 of 5.5 nM and modestly potent to Pyk2(IC50=3.5 nM); 10- to 100-fold less potent against InsR, IGF-1R, ALK, and c-Met.
-
Rilotumumab
Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling.
-
BAY-474
BAY-474 is an inhibitor of tyrosine-protein kinase c-Met.?It acts as an epigenetics probe.
